Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,032 | 182,476 | 41,574 | 187,620 | 185,420 |
| Marketable Securities | 114,648 | 7,966 | 80,091 | 106,301 | 84,200 |
| Other current assets | 674 | 14,667 | 2,254 | 246 | 0 |
| TOTAL | $181,293 | $211,886 | $142,976 | $296,618 | $270,579 |
| Non-Current Assets | |||||
| PPE Net | 20,572 | 24,404 | 22,659 | 19,009 | 4,932 |
| Other Non-Current Assets | 140,868 | 61,218 | 28,216 | 44,687 | 26,345 |
| TOTAL | $161,440 | $85,622 | $50,875 | $63,696 | $31,277 |
| Total Assets | $342,733 | $297,508 | $193,851 | $360,314 | $301,856 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,887 | 11,351 | 19,537 | 4,332 | 1,435 |
| Accrued Expenses | 12,600 | 15,904 | 27,610 | 10,688 | 37,192 |
| Other current liabilities | N/A | N/A | N/A | N/A | 12,020 |
| TOTAL | $37,448 | $37,961 | $56,423 | $26,714 | $57,983 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,824 | 7,092 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 126,290 | 43,180 | 4,357 | 17,051 | 3,070 |
| TOTAL | $184,417 | $106,398 | $4,357 | $17,330 | $4,313 |
| Total Liabilities | $221,865 | $144,359 | $60,780 | $44,044 | $62,296 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 180,552 | 131,161 | 119,939 | 97,246 | N/A |
| Common Shares | 2 | 2 | 2 | 2 | N/A |
| Retained earnings | -888,354 | -687,212 | -491,330 | -293,197 | -171,376 |
| Other shareholders' equity | 82 | 1 | -15 | -384 | 395,773 |
| TOTAL | $120,868 | $153,149 | $133,071 | $316,270 | $239,560 |
| Total Liabilities And Equity | $342,733 | $297,508 | $193,851 | $360,314 | $301,856 |